dsm-firmenich Updates Share Repurchase Progress

Corporate Action
โดย dsm-firmenich·CH·Read original
Summary · why it matters

dsm-firmenich has provided a weekly update on its share repurchase program, which was announced on February 9, 2026, to repurchase shares worth €500 million and reduce issued capital. The program was expanded on March 12, 2026, to a total of €540 million, with €40 million earmarked for share-based compensation plans and €500 million for capital reduction. Between August 31 and September 4, 2026, the company repurchased 275,000 shares at an average price of €94.52 per share, totaling €26.0 million. To date, the company has repurchased 6,017,212 shares at an average price of €71.69, for a total consideration of €431.4 million. The €40 million buyback for compensation plans was completed on March 23, 2026, and the €500 million capital reduction program is expected to conclude by the end of Q3 2026.

Impact on stocks 2

Synthetic Biology (non-pharma) · 1 stocks
DSM-Firmenich AG
DSFIR
▲ PositiveCapitalrelevance

Company updates on its share repurchase program, indicating ongoing capital return to shareholders.

Critical Materials & Supply Chain · 1 stocks